Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature
- PMID: 18336875
- PMCID: PMC2695137
- DOI: 10.1016/j.semarthrit.2008.01.011
Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature
Abstract
Objective: Nonadherence with medication treatment has been found to occur in large proportions of patients with a broad range of chronic conditions. Our aim was to perform a systematic review of the literature examining adherence with treatments for inflammatory rheumatic conditions to assess the magnitude of the problem in this patient population.
Methods: A MEDLINE search of English language literature was performed to identify studies published between January 1, 1985 and November 30, 2007 that evaluated adherence with chronic medications needed in the treatment of rheumatic conditions.
Results: A total of 20 articles met the criteria for evaluation, the majority of which focused on the treatment of rheumatoid arthritis. Most of the studies examined the use of nonsteroidal anti-inflammatory medications and disease-modifying antirheumatic drugs. Adherence was assessed based on self-report, pill counts, pharmacy dispensings, openings of pill containers using electronic devices, laboratory assays, and physician assessment. Adherence varied greatly based on the adherence measure used, arthritic condition evaluated, and medication under study. Overall, the highest rates of adherence were based on self-reports for a wide variety of medications and conditions (range of persons reporting adherence was 30 to 99%), while the lowest adherence rates were for allopurinol based on pharmacy dispensings (18-26%).
Conclusions: Adherence has not been widely examined for most chronic inflammatory rheumatic conditions and the few studies that exist used different definitions and populations, thus limiting any conclusions. However, the current literature does suggest that nonadherence is a substantial problem.
Similar articles
-
A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.Rheumatol Int. 2017 Oct;37(10):1619-1628. doi: 10.1007/s00296-017-3763-9. Epub 2017 Jul 5. Rheumatol Int. 2017. PMID: 28681249 Review.
-
What are the effects of medication adherence interventions in rheumatic diseases: a systematic review.Ann Rheum Dis. 2016 Apr;75(4):667-73. doi: 10.1136/annrheumdis-2014-206593. Epub 2015 Feb 9. Ann Rheum Dis. 2016. PMID: 25667208 Review.
-
Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.Joint Bone Spine. 2019 Jan;86(1):13-19. doi: 10.1016/j.jbspin.2018.08.006. Epub 2018 Sep 19. Joint Bone Spine. 2019. PMID: 30243782 Review.
-
The adherence questionnaires in chronic inflammatory rheumatic diseases and their psychometric properties: A systematic literature review.Joint Bone Spine. 2021 May;88(3):105160. doi: 10.1016/j.jbspin.2021.105160. Epub 2021 Feb 9. Joint Bone Spine. 2021. PMID: 33578034 No abstract available.
-
Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease.Joint Bone Spine. 2022 Nov;89(6):105449. doi: 10.1016/j.jbspin.2022.105449. Epub 2022 Aug 6. Joint Bone Spine. 2022. PMID: 35944599 No abstract available.
Cited by
-
Predictors of medication non-adherence for vasculitis patients.Clin Rheumatol. 2013 May;32(5):649-57. doi: 10.1007/s10067-013-2164-z. Epub 2013 Jan 12. Clin Rheumatol. 2013. PMID: 23314654 Free PMC article.
-
Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.Rheumatol Int. 2018 Mar;38(3):467-472. doi: 10.1007/s00296-018-3930-7. Epub 2018 Jan 22. Rheumatol Int. 2018. PMID: 29356882
-
Ranking facilitators and barriers of medication adherence by patients with inflammatory arthritis: a maximum difference scaling exercise.BMC Musculoskelet Disord. 2021 Jan 6;22(1):21. doi: 10.1186/s12891-020-03874-2. BMC Musculoskelet Disord. 2021. PMID: 33407344 Free PMC article.
-
Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada.Rheumatol Ther. 2022 Oct;9(5):1399-1420. doi: 10.1007/s40744-022-00485-2. Epub 2022 Sep 1. Rheumatol Ther. 2022. PMID: 36045308 Free PMC article.
-
Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study.Rheumatol Int. 2010 Sep;30(11):1441-8. doi: 10.1007/s00296-009-1160-8. Epub 2009 Oct 13. Rheumatol Int. 2010. PMID: 19823840
References
-
- Rogers PGBW. Prescription medication compliance: a review of the baseline of knowledge. A report of the national council on patient information and patient education. Journal of Pharmacoepidemiology and Drug Safety. 1995;2:3–36.
-
- Sackett DLHR. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press; 1976.
-
- Gerth WC. Compliance and persistence with newer antihypertensive agents. Curr Hypertens Rep. 2002;4(6):424–33. - PubMed
-
- Buchbinder R, Hall S, Sambrook PN, et al. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol. 1993;20(4):639–44. - PubMed
-
- Osterberg L, Blaschke T. Adherence to medication [see comment] N Engl J Med. 2005;353(5):487–97. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous